Current Clinical Trials

ALXN-MG-501: Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies
  1. Samir Macwan, MD
    Samir Macwan, MD
  2. for people 18 to 99 (full criteria)
  3. Rancho Mirage, CA
  4. study started November 2019
  5. Samir Macwan, MD
  6. Accepting new patients

Description

Summary

This is a long-term, multicenter, observational, registry of patients with gMG who are treated with ALXN-C5IT prior to enrollment. Physicians will perform the study in full accordance with the Food and Drug Administration (FDA)-approved drug’s indication and according to current clinical practice in their center with currently available treatment resources, patient-reported outcome (PRO) instruments, and information and in accordance with the regulations and guidelines governing medical practice and ethics in the US.

Official Title

ALXN-MG-501:Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies

Detailed Description

ERR ... more
less

ERR

Keywords

Myasthenia Gravis

Eligibility

for people 18 to 99
ERR ... more
less

ERR

Lead Scientist at Eisenhower Health

Samir Macwan, MD
Dr. Samir Macwan served as a section chief of Neurology at Eisenhower Medical Center between 2012 to 2015. He is Board Certified in Neurology and Neuromuscular Medicine.  Prior to completing an Internal Medicine internship at New York Medical College Dr. Macwan did a research fellowship in Headache/Cranial Neuralgia at University of Southern California. He performed a Neurology residency and Clinical Neurophysiology fellowship at University of Kansas Medical Center. He has been trained u... more
less

Dr. Samir Macwan served as a section chief of Neurology at Eisenhower Medical Center between 2012 to 2015. He is Board Certified in Neurology and Neuromuscular Medicine. 

Prior to completing an Internal Medicine internship at New York Medical College Dr. Macwan did a research fellowship in Headache/Cranial Neuralgia at University of Southern California. He performed a Neurology residency and Clinical Neurophysiology fellowship at University of Kansas Medical Center. He has been trained under internationally acclaimed neuromuscular expert Dr. Richard Barohn. 

Dr. Macwan has been practicing Neuromuscular Medicine in the Greater Palm Springs area for 10 years. He is a member of MG care as well a speaker at the national meeting of Myasthenia Gravis Foundation of America. He is also on the advisory board member of Myasthenia Gravis Foundation of California. He has been involved in research of Myasthenia Gravis as well as Immune Mediated Polyneuropathy in Diabetes and Small Fiber Neuropathy. Dr. Macwan moderates and speaks at support groups for MG patients and caregivers. 

Dr. Macwan is professionally trained in performing botulinum toxin injections in cervical dystonia/focal dystonias, chronic migraine, muscle spasticity, sialorrhea and facial spasm.

Clinical Study Details

  1. Accepting new patients
  2. study started November 2019
  3. Observational [Patient Registry]
  4. March 06, 2024